Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19

被引:96
|
作者
Abramowicz, Mark
机构
来源
关键词
D O I
10.1001/jama.2021.24931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:384 / 385
页数:2
相关论文
共 50 条
  • [1] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1641): : 1 - 2
  • [2] Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
    Nguyen, Yann
    Flahault, Adrien
    Chavarot, Nathalie
    Melenotte, Clea
    Cheminant, Morgane
    Deschamps, Paul
    Carlier, Nicolas
    Lafont, Emmanuel
    Thomas, Marion
    Flamarion, Edouard
    Lebeaux, David
    Charlier, Caroline
    Rachline, Anne
    Guerin, Corinne
    Ratiney, Robert
    Touchard, Justine
    Pere, Helene
    Rozenberg, Flore
    Lanternier, Fanny
    Arlet, Jean-Benoit
    Avouac, Jerome
    Boussaud, Veronique
    Guillemain, Romain
    Vignon, Marguerite
    Thervet, Eric
    Scemla, Anne
    Weiss, Laurence
    Mouthon, Luc
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1654.e1 - 1654.e4
  • [3] TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19: AMONOCENTRIC STUDY IN KIDNEY TRANSPLANT RECIPIENTS
    Stefanelli, Lucia Federica
    Alessi, Marianna
    Ungaro, Claudia
    Ciotti, Chiara
    Calo, Lorenzo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I942 - I942
  • [4] Real World Efficacy of COVID-19 Pre-exposure Prophylaxis with tixagevimab/cilgavimab (Evusheld) in People with Multiple Sclerosis
    Tremblay, M. A.
    Elias, L. B.
    Jaber, A. F.
    Manzano, M.
    Leekoff, M.
    Sylvester, A. W.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 72 - 73
  • [5] Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
    Desai, Aakash
    Hashash, Jana G.
    Kochhar, Gursimran S.
    Farraye, Francis A.
    [J]. CROHNS & COLITIS 360, 2023, 5 (03)
  • [6] Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19
    Zhuravleva, Marina, V
    Chulanov, Vladimir P.
    Gagarina, Julia, V
    Shabalina, Elena A.
    [J]. TERAPEVTICHESKII ARKHIV, 2023, 95 (01): : 66 - 77
  • [7] Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Eleutherakis-Papaiakovou, Evangelos
    Malandrakis, Panagiotis
    Spiliopoulou, Vassiliki
    Syrigou, Rodanthi-Eleni
    Theodorakakou, Foteini
    Fotiou, Despina
    Migkou, Magdalini
    Roussou, Maria
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Terpos, Evangelos
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S302 - S303
  • [8] Safety and Tolerability of Tixagevimab/Cilgavimab for Pre-Exposure Prophylaxis of COVID-19 in Kidney Transplant Recipients
    Salinas, Thalia
    Stryjniak, Gabriel J.
    Lee, John R.
    Sawinski, Deirdre L.
    Muthukumar, Thangamani
    Dadhania, Darshana M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 554 - 555
  • [9] Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
    Fernandez-Prada, Maria
    Perez-Martin, Jaime Jesus
    Cienfuegos-Gonzalez, Paula
    [J]. MEDICINA CLINICA, 2023, 160 (10): : 458 - 459
  • [10] Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cilgavimab for COVID-19 among Immunocompromised Pediatric Patients
    Fraczkiewicz, Jowita
    Pawinska-Wasikowska, Katarzyna
    Szymbor, Katarzyna
    Balwierz, Walentyna
    Skoczen, Szymon
    Czyzewski, Krzysztof
    Koltan, Sylwia
    Styczynski, Jan
    Malecka, Anna
    Irga-Jaworska, Ninela
    Trelinska, Joanna
    Mlynarski, Wojciech
    Zajac-Spychala, Olga
    Sobkowiak-Sobierajska, Agnieszka
    Derwich, Katarzyna
    Bal, Wioletta
    Chaber, Radoslaw
    Ksiazek, Agnieszka
    Szczepanski, Tomasz
    Zawitkowska, Joanna
    Drabko, Katarzyna
    Chodala-Grzywacz, Agnieszka
    Karolczyk, Grazyna
    Kobierzycki, Christopher
    Kalwak, Krzysztof
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)